Kunal Karamchandani, MD
Anesthesiology · Dallas, TXNPI 1568638138
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (31.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Eagle Pharmaceuticals, Inc. at 55.5% of the total. Reporting peaked in 2022 at $4,575 and has fallen 54.2% since, to $2,094 in 2025. Among anesthesiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $318.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eagle Pharmaceuticals, Inc.$4K
- Philips North America LLC$2K
- AOP Health US, LLC$206
- Abiomed$170
- Vyaire Medical, Inc.$165
- Monaghan Medical Corporation$150
- plus $278 from 5 others
Across 58 payments — averaging $2191.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$127K
What the payments were for
- Consulting fees$2,43132%
- Speaking & faculty fees$2,32030%
- Travel & lodging$1,35218%
- Food & beverage$1,54320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eagle Pharmaceuticals, Inc. | 11 | $4,246 |
| Philips North America LLC | 2 | $2,431 |
| AOP Health US, LLC | 1 | $206 |
| Abiomed | 2 | $170 |
| Vyaire Medical, Inc. | 1 | $165 |
| Monaghan Medical Corporation | 1 | $150 |
| Chiesi USA, Inc. | 1 | $115 |
| Fisher & Paykel Healthcare Inc | 1 | $61 |
| Merck | 2 | $44 |
| Abbott | 1 | $35 |
| Octapharma USA, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Respiratory$1,838
- (1439) HPM Undiv$593
- Rapiblyk$411
- BYFAVO$265
- BARHEMSYS$164
- Aerobika$150
- Impella$141
- CLEVIPREX$115
How this compares
$7,646 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Dallas
- James MuellerDallas$636K
- Girish JoshiDallas$239K
- Christina RiccioDallas$131K
- Richard DuttonDallas$105K
- Shawn ThomasDallas$77K
- Kelly LeblancDallas$70K
- Michael WalshDallas$66K
- Holly BarkoDallas$66K
- Melissa BurgerDallas$30K
- Amy MarinoDallas$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.